Co-Diagnostics Inc
NASDAQ:CODX
Co-Diagnostics Inc
NASDAQ:CODX
Price:
1.21 USD
0.83%
Market Closed
Updated:
May 5, 2024
Co-Diagnostics Inc
Revenue
|
Co-Diagnostics Inc
Revenue Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Co-Diagnostics Inc
NASDAQ:CODX
|
Revenue
$6.8m
|
CAGR 3-Years
-55%
|
CAGR 5-Years
179%
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Co-Diagnostics Inc
Revenue Breakdown
Breakdown by Geography
Co-Diagnostics Inc
Co-Diagnostics Inc
Not Available
Breakdown by Segments
Co-Diagnostics Inc
Co-Diagnostics Inc
|
Total Revenue:
6.8m
USD
|
|
Grant Revenue:
5.8m
USD
|
|
Product Revenue:
991.5k
USD
|
See Also
What is Co-Diagnostics Inc's Revenue?
Revenue
6.8m
USD
6.8m
USD
Based on the financial report for Dec 31, 2023, Co-Diagnostics Inc's Revenue amounts to 6.8m USD.
What is Co-Diagnostics Inc's Revenue growth rate?
Revenue CAGR 5Y
179%
179%
Over the last year, the Revenue growth was -80%. The average annual Revenue growth rates for Co-Diagnostics Inc have been -55% over the past three years , 179% over the past five years .
You don't have any saved screeners yet
